[EN] FUSED PYRIMIDINEONE COMPOUNDS AS TRPV3 MODULATORS<br/>[FR] COMPOSÉS DE PYRIMIDINONE CONDENSÉS À TITRE DE MODULATEURS DES TRP V3
申请人:GLENMARK PHARMACEUTICALS SA
公开号:WO2009130560A1
公开(公告)日:2009-10-29
The present invention provides transient receptor potential vanilloid (TRPV) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRP V3. Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPV3.